BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8254210)

  • 21. Evidence for the involvement of endotoxin in toxic shock syndrome.
    Stone RL; Schlievert PM
    J Infect Dis; 1987 Apr; 155(4):682-9. PubMed ID: 2950183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology.
    Betley MJ; Borst DW; Regassa LB
    Chem Immunol; 1992; 55():1-35. PubMed ID: 1418613
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.
    Schlievert PM; Jablonski LM; Roggiani M; Sadler I; Callantine S; Mitchell DT; Ohlendorf DH; Bohach GA
    Infect Immun; 2000 Jun; 68(6):3630-4. PubMed ID: 10816521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.
    Christensson B; Johansson PJ; Oxelius VA
    Clin Exp Immunol; 1986 Nov; 66(2):443-9. PubMed ID: 3815898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of biologically active region in toxic shock syndrome toxin 1.
    Kokan-Moore NP; Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S125-9. PubMed ID: 2467343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the Today contraceptive sponge on growth and toxic shock syndrome toxin-1 production by Staphylococcus aureus.
    Remington KM; Buller RS; Kelly JR
    Obstet Gynecol; 1987 Apr; 69(4):563-9. PubMed ID: 3822297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
    Bonventre PF; Heeg H; Edwards CK; Cullen CM
    Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth and analysis of crystal forms of toxic shock syndrome toxin 1.
    Earhart CA; Prasad GS; Murray DL; Novick RP; Schlievert PM; Ohlendorf DH
    Proteins; 1993 Nov; 17(3):329-34. PubMed ID: 8272430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A toxic shock syndrome toxin mutant of Staphylococcus aureus isolated by allelic replacement lacks virulence in a rabbit uterine model.
    Sloane R; de Azavedo JC; Arbuthnott JP; Hartigan PJ; Kreiswirth B; Novick R; Foster TJ
    FEMS Microbiol Lett; 1991 Mar; 62(2-3):239-44. PubMed ID: 2040432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.
    Reeves MW; Arko RJ; Chandler FW; Bridges NB
    Infect Immun; 1986 Feb; 51(2):431-9. PubMed ID: 3943896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of Staphylococcus aureus toxic shock exotoxin on whole blood cell chemiluminescence in vitro and in vivo].
    Antipov AIu; Shepelev AP; Poliakov VM
    Vopr Med Khim; 1995; 41(2):40-2. PubMed ID: 7793095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of tumor necrosis factor alpha by human peritoneal macrophages in response to toxic shock syndrome toxin-1.
    Buyalos RP; Rutanen EM; Tsui E; Halme J
    Obstet Gynecol; 1991 Aug; 78(2):182-6. PubMed ID: 2067760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing.
    Blomster-Hautamaa DA; Kreiswirth BN; Novick RP; Schlievert PM
    Biochemistry; 1986 Jan; 25(1):54-9. PubMed ID: 3954993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation.
    Cullen CM; Blanco LR; Bonventre PF; Choi E
    Infect Immun; 1995 Jun; 63(6):2141-6. PubMed ID: 7768593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model.
    Rasheed JK; Arko RJ; Feeley JC; Chandler FW; Thornsberry C; Gibson RJ; Cohen ML; Jeffries CD; Broome CV
    Infect Immun; 1985 Mar; 47(3):598-604. PubMed ID: 3156093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays.
    Bohach GA; Kreiswirth BN; Novick RP; Schlievert PM
    Rev Infect Dis; 1989; 11 Suppl 1():S75-81; discussion S81-2. PubMed ID: 2494691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of toxic shock syndrome toxin-1 gene in Staphylococcus aureus.
    Woo JH; Kim YS; Hwang SD
    Mol Cells; 1997 Feb; 7(1):28-33. PubMed ID: 9085261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome.
    Musser JM; Schlievert PM; Chow AW; Ewan P; Kreiswirth BN; Rosdahl VT; Naidu AS; Witte W; Selander RK
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):225-9. PubMed ID: 1967495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of staphylococci for the toxic shock syndrome toxin-1 (TSST-1) gene.
    Jaulhac B; De Buyser ML; Dilasser F; Prevost G; Piedmont Y
    Lett Appl Microbiol; 1991 Aug; 13(2):90-2. PubMed ID: 1367543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal tampon model for toxic shock syndrome.
    Melish ME; Murata S; Fukunaga C; Frogner K; McKissick C
    Rev Infect Dis; 1989; 11 Suppl 1():S238-46; discussion S246-7. PubMed ID: 2928642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.